Literature DB >> 20959666

Effect of delayed formalin fixation on estrogen and progesterone receptors in breast cancer: a study of three different clones.

Jingxin Qiu1, Swati Kulkarni, Rameela Chandrasekhar, Mark Rees, Kathryn Hyde, Gregory Wilding, Dongfeng Tan, Thaer Khoury.   

Abstract

We previously reported that delayed formalin fixation (DFF) has a negative effect on immunohistochemical staining of estrogen receptor (ER), progesterone receptor (PR), and HER2. The primary aim of the study was to determine if DFF affected commonly used clones of the ER and PR differentially. The specific clones evaluated were ER clones 1D5, 6F11, and SP1 and PR clones 16, 1E2, and PgR636. Ten breast cancer cases were dissected and fixed at different times (0, 10, and 30 minutes; 1, 2, 4, and 8 hours; and overnight) and were then stained with anti-ER and anti-PR antibodies. The mean Q score for ER started to decline at 2 to 4 hours for clones 1D5 and 6F11 and at 1 hour for SP1. SP1 was superior to 1D5 at the 8-hour mark (P = .03). The Q score for PR started to decline at 1 hour for clones PgR636 and 16 and 4 to 8 hours for 1E2 (P = .03). Based on our findings, it appears that regardless of the antibody clones evaluated, DFF has a negative effect on hormone receptors.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20959666     DOI: 10.1309/AJCPVCX83JWMSBNO

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  16 in total

1.  Impact of delayed fixation and decalcification on PD-L1 expression: a comparison of two clones.

Authors:  Fabien Forest; Gaelle Cote; David Laville; Vanessa Da Cruz; Pierre Dal Col; Florian Camy; Mousa Mobarki; Alix Clemenson; Violaine Yvorel; Michel Péoc'h
Journal:  Virchows Arch       Date:  2019-07-02       Impact factor: 4.064

2.  Cytoplasmic estrogen receptor in breast cancer.

Authors:  Allison W Welsh; Donald R Lannin; Gregory S Young; Mark E Sherman; Jonine D Figueroa; N Lynn Henry; Lisa Ryden; Chungyeul Kim; Richard R Love; Rachel Schiff; David L Rimm
Journal:  Clin Cancer Res       Date:  2011-10-06       Impact factor: 12.531

3.  Quantitative analysis of estrogen receptor expression shows SP1 antibody is more sensitive than 1D5.

Authors:  Allison W Welsh; Malini Harigopal; Hallie Wimberly; Manju Prasad; David L Rimm
Journal:  Appl Immunohistochem Mol Morphol       Date:  2013-03

4.  The effect of prolonged cold ischemia time on estrogen receptor immunohistochemistry in breast cancer.

Authors:  Xiaoxian Li; Michael T Deavers; Ming Guo; Ping Liu; Yun Gong; Constance T Albarracin; Lavinia P Middleton; Lei Huo
Journal:  Mod Pathol       Date:  2012-08-17       Impact factor: 7.842

Review 5.  Effects of Cold Ischemia on Gene Expression: A Review and Commentary.

Authors:  William E Grizzle; Dennis Otali; Katherine C Sexton; Daniel S Atherton
Journal:  Biopreserv Biobank       Date:  2016-08-23       Impact factor: 2.300

Review 6.  Role of oestrogen receptors in bladder cancer development.

Authors:  Iawen Hsu; Spencer Vitkus; Jun Da; Shuyuan Yeh
Journal:  Nat Rev Urol       Date:  2013-04-16       Impact factor: 14.432

7.  Evaluation of three commercial progesterone receptor assays in a single tamoxifen-treated breast cancer cohort.

Authors:  Elizabeth N Kornaga; Alexander C Klimowicz; Natalia Guggisberg; Travis Ogilvie; Don G Morris; Marc Webster; Anthony M Magliocco
Journal:  Mod Pathol       Date:  2016-08-26       Impact factor: 7.842

8.  Impact of Preanalytical Factors on the Measurement of Tumor Tissue Biomarkers Using Immunohistochemistry.

Authors:  Aditi Bagchi; Zachary Madaj; Kelly B Engel; Ping Guan; Daniel C Rohrer; Dana R Valley; Emily Wolfrum; Kristin Feenstra; Nancy Roche; Galen Hostetter; Helen M Moore; Scott D Jewell
Journal:  J Histochem Cytochem       Date:  2021-03-01       Impact factor: 2.479

9.  The Effect of Cold Ischemia Time and/or Formalin Fixation on Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor-2 Results in Breast Carcinoma.

Authors:  Melike Pekmezci; Anna Szpaderska; Clodia Osipo; Cağatay Erşahin
Journal:  Patholog Res Int       Date:  2012-03-11

10.  Ki-67 Expression in Breast Cancer Tissue Microarrays: Assessing Tumor Heterogeneity, Concordance With Full Section, and Scoring Methods.

Authors:  Thaer Khoury; Gary Zirpoli; Stephanie M Cohen; Joseph Geradts; Angela Omilian; Warren Davis; Wiam Bshara; Ryan Miller; Michelle M Mathews; Melissa Troester; Julie R Palmer; Christine B Ambrosone
Journal:  Am J Clin Pathol       Date:  2017-08-01       Impact factor: 2.493

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.